Pharmacological Strategies in the Prevention of Migraine in Children


Drug

Evidence level

Dosage

Study design

References

Dose frequency

Flunazine

A

5–10 mg

DBPC; OL

[8, 9]

Once per die

Topiramate

A

1–2 mg/kg

BDPC

[1214]

Once per die

Valproate

B

15–45 mg/kg

OL; DBPC; rDBPC

[1517, 19]

Once/twice per die

Amitriptyline

C

0.25–1 mg/kg

RR, OL

[20, 21]

Once per die

Propanolol

C

1–2 mg/kg

DBPC

[2224]

Once per die

Pizotifen

C

0.5–1.5 mg/kg

DBPCCO

[26]

Once per die


Literature references and study designs are also reported: DBPC double-blind placebo-controlled, DBPCCO double-blind placebo-controlled crossover, rDBPC randomized double-blind placebo controlled, OL open-label, RR retrospective review





References



1.

Brenner M, Lewis D (2008) The treatment of migraine headaches in children and adolescents. J Pediatr Pharmacol Ther 13(1):17–24


2.

O’Brien HL, Kabbouche MA, Kacperski J et al (2015) Treatment of pediatric migraine. Curr Treat Options Neurol 17(1):326


3.

Silberstein SD (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55(6):754–762CrossRef


4.

Evers S, Afra J, Frese A et al (2006) EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur J Neurol 13(6):560–572CrossRef


5.

Lanzi G, Balottin U, Zambrino CA et al (1996) Guidelines and recommendations for the treatment of migraine in paediatric and adolescent patients. Italian Society for the Study of Headache. Funct Neurol 11(5):269–275


6.

El-Chammas K, Keyes J, Thompson N et al (2013) Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr 167(3):250–258CrossRef


7.

Autret A, Valade D, Debiais S (2012) Placebo and other psychological interactions in headache treatment. J Headache Pain 13(3):191–198CrossRef


8.

Sorge F, De Simone R, Marano E et al (1988) Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 8(1):1–6CrossRef


9.

Guidetti V, Moscato D, Ottaviano S et al (1987) Flunarizine and migraine in childhood. An evaluation of endocrine function. Cephalalgia 7(4):263–266CrossRef


10.

Lewis DW, Winner P (2006) The pharmacological treatment options for pediatric migraine: an evidence-based appraisal. NeuroRx 3(2):181–191CrossRef


11.

Oakley CB, Kossoff EH (2014) Migraine and epilepsy in the pediatric population. Curr Pain Headache Rep 18(3):402CrossRef
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 22, 2016 | Posted by in PHARMACY | Comments Off on Pharmacological Strategies in the Prevention of Migraine in Children

Full access? Get Clinical Tree

Get Clinical Tree app for offline access